{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:31:12Z","timestamp":1788442272985,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:00:00Z","timestamp":1758931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00259-025-07546-y","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T03:26:23Z","timestamp":1758943583000},"page":"1811-1821","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Superiority of long axial field-of-view 68Ga-PSMA-11 PET over short axial field-of-view PET in prostate cancer: a head-to-head comparison"],"prefix":"10.1007","volume":"53","author":[{"given":"Yining","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1939-3978","authenticated-orcid":false,"given":"Gang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruohua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,27]]},"reference":[{"key":"7546_CR1","doi-asserted-by":"publisher","unstructured":"Cancer statistics. CA Cancer J Clin. 2022, 2022; https:\/\/doi.org\/10.3322\/caac.21708.","DOI":"10.3322\/caac.21708"},{"issue":"5","key":"7546_CR2","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.semnuclmed.2023.02.006","volume":"53","author":"V Jeet","year":"2023","unstructured":"Jeet V, Parkinson B, Song R, Sharma R, Hoyle M. Histopathologically validated diagnostic accuracy of PSMA-PET\/CT in the primary and secondary staging of prostate cancer and the impact of PSMA-PET\/CT on clinical management: a systematic review and meta-analysis. Semin Nucl Med. 2023;53(5):706\u201318.","journal-title":"Semin Nucl Med"},{"issue":"3","key":"7546_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1109\/TRPMS.2020.2985403","volume":"4","author":"S Surti","year":"2020","unstructured":"Surti S, Pantel AR, Karp JS. Total body PET: why, how, what for? IEEE Trans Radiat Plasma Med Sci. 2020;4(3):283\u201392.","journal-title":"IEEE Trans Radiat Plasma Med Sci"},{"key":"7546_CR4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2967\/jnumed.120.250597","volume":"62","author":"BA Spencer","year":"2021","unstructured":"Spencer BA, Berg E, Schmall JP, et al. Performance evaluation of the uEXPLORER total-body PET\/CT scanner based on NEMA NU 2\u20132018 with additional tests to characterize PET scanners with a long axial field of view. J Nucl Med. 2021;62:861\u201370.","journal-title":"J Nucl Med"},{"issue":"13","key":"7546_CR5","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1007\/s00259-023-06355-5","volume":"50","author":"Y Wang","year":"2023","unstructured":"Wang Y, Chen Z, Zhu Y, Zhao H, Li L, Huang G, et al. Total-body [(68) Ga]Ga-PSMA-11 PET\/CT improves detection rate compared with conventional [(68) Ga]Ga-PSMA-11 PET\/CT in patients with biochemical recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2023;50(13):4096\u2013106.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"7546_CR6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2967\/jnumed.117.198119","volume":"59","author":"M Eiber","year":"2018","unstructured":"Eiber M, Herrmann K, Calais J, et al. Prostate cancer molecular imaging standardized evaluation (PROMISE): proposed mitnm classification for the interpretation of PSMA-ligand PET\/CT. J Nucl Med. 2018;59(3):469\u201378.","journal-title":"J Nucl Med"},{"key":"7546_CR7","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s00259-017-3780-7","volume":"44","author":"S Sheikhbahaei","year":"2017","unstructured":"Sheikhbahaei S, Afshar-Oromieh A, Eiber M, Solnes LB, Javadi MS, Ross AE, et al. Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging. Eur J Nucl Med Mol Imaging. 2017;44:2117\u201336. https:\/\/doi.org\/10.1007\/s00259-017-3780-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"7546_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2967\/jnumed.119.227801","volume":"61","author":"J van Sluis","year":"2020","unstructured":"van Sluis J, Boellaard R, Somasundaram A, et al. Image quality and semiquantitative measurements on the biograph vision PET\/CT system: initial experiences and comparison with the biograph mCT. J Nucl Med. 2020;61(1):129\u201335.","journal-title":"J Nucl Med"},{"issue":"12","key":"7546_CR9","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1007\/s00259-022-05893-8","volume":"49","author":"W Chen","year":"2022","unstructured":"Chen W, Liu L, Li Y, et al. Evaluation of pediatric malignancies using total-body PET\/CT with half-dose [18F]-FDG. Eur J Nucl Med Mol Imaging. 2022;49(12):4145\u201355.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"7546_CR10","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1007\/s00259-023-06185-5","volume":"50","author":"N Solomonidou","year":"2023","unstructured":"Solomonidou N, Germanou D, Strouthos I, et al. PSMA-PET\/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA\u2009<\u20090.2 ng\/ml. Eur J Nucl Med Mol Imaging. 2023;50(8):2529\u201336.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"7546_CR11","doi-asserted-by":"publisher","first-page":"902","DOI":"10.2967\/jnumed.122.265025","volume":"64","author":"I Sonni","year":"2023","unstructured":"Sonni I, Dal Pra A, O'Connell DP, et al. 68Ga-PSMA PET\/CT-Based Atlas for Prostate Bed Recurrence After Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy Contouring Guidelines. J Nucl Med. 2023;64(6):902\u20139.","journal-title":"J Nucl Med."},{"issue":"1","key":"7546_CR12","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/RLU.0000000000004430","volume":"48","author":"KR Chandekar","year":"2023","unstructured":"Chandekar KR, Singh H, Kumar R, et al. Comparison of 18 F-PSMA-1007 PET\/CT with 68 Ga-PSMA-11 PET\/CT for initial staging in intermediate- and high-risk prostate cancer. Clin Nucl Med. 2023;48(1):e1\u20138.","journal-title":"Clin Nucl Med"},{"key":"7546_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/bju.13540","volume":"119","author":"PJ van Leeuwen","year":"2017","unstructured":"van Leeuwen PJ, Emmett L, Ho B, Delprado W, Ting F, Nguyen Q, et al. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography\/computed tomography for preoperative lymph node staging in prostate cancer. BJU Int. 2017;119:209\u201315. https:\/\/doi.org\/10.1111\/bju.13540.","journal-title":"BJU Int"},{"issue":"1","key":"7546_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41391-022-00581-y","volume":"26","author":"H Huo","year":"2023","unstructured":"Huo H, Shen S, He D, Liu B, Yang F. Head-to-head comparison of 68Ga-PSMA-11 PET\/CT and 68Ga-PSMA-11 PET\/MRI in the detection of biochemical recurrence of prostate cancer: summary of head-to-head comparison studies. Prostate Cancer Prostatic Dis. 2023;26(1):16\u201324.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"7546_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13550-023-00999-y","volume":"13","author":"C Margail","year":"2023","unstructured":"Margail C, Merlin C, Billoux T, et al. Imaging quality of an artificial intelligence denoising algorithm: validation in 68Ga PSMA-11 PET for patients with biochemical recurrence of prostate cancer. EJNMMI Res. 2023;13(1):50 (Published 2023 May 25).","journal-title":"EJNMMI Res"},{"issue":"7","key":"7546_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13071594","volume":"13","author":"A Fourquet","year":"2021","unstructured":"Fourquet A, Lahmi L, Rusu T, et al. Restaging the biochemical recurrence of prostate cancer with [68Ga]Ga-PSMA-11 PET\/CT: diagnostic performance and impact on patient disease management. Cancers (Basel). 2021;13(7):1594.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"7546_CR17","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1007\/s00259-014-2751-5","volume":"41","author":"D Izquierdo-Garcia","year":"2014","unstructured":"Izquierdo-Garcia D, Sawiak SJ, Knesaurek K, et al. Comparison of MR-based attenuation correction and CT-based attenuation correction of whole-body PET\/MR imaging. Eur J Nucl Med Mol Imaging. 2014;41(8):1574\u201384.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"7546_CR18","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.2967\/jnumed.112.113209","volume":"54","author":"I Bezrukov","year":"2013","unstructured":"Bezrukov I, Schmidt H, Mantlik F, et al. MR-based attenuation correction methods for improved PET quantification in lesions within bone and susceptibility artifact regions. J Nucl Med. 2013;54(10):1768\u201374.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07546-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07546-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07546-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:43:10Z","timestamp":1769834590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07546-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,27]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7546"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07546-y","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,27]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study involving human participants was in line with the principles of the ethics committee in Renji hospital and the declaration of Helsinki in 1964. Animal-based research was not included in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No potential conflict of interest was reported.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The informed consent was obtained from all patients.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}